Genfit S.A. (EPA:GNFT)
France · Delayed Price · Currency is EUR 8.63
0.00 (0.00%)
Apr 2, 2026, 5:35 PM CET
Genfit Market Cap
Genfit has a market cap or net worth of €429.73 million as of April 2, 2026. Its market cap has increased by 158.80% in one year.
Market Cap
429.73M
Enterprise Value
461.14M
Revenue
45.13M
Ranking
n/a
PE Ratio
n/a
Stock Price
€8.63
Market Cap Chart
Since December 20, 2006, Genfit's market cap has increased from 146.07M to 429.73M, an increase of 194.20%. That is a compound annual growth rate of 5.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 429.73M | 63.91% |
| Dec 31, 2025 | 262.17M | 48.73% |
| Dec 31, 2024 | 176.27M | 0.17% |
| Dec 29, 2023 | 175.98M | -10.69% |
| Dec 30, 2022 | 197.03M | -8.19% |
| Dec 31, 2021 | 214.62M | 38.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nanobiotix | 1.40B |
| DBV Technologies | 1.04B |
| Inventiva | 873.97M |
| MedinCell | 829.39M |
| Valneva SE | 490.33M |
| Sensorion | 218.76M |
| Cellectis | 218.50M |
| Transgene | 209.75M |